Related Experiment Video
Updated: Jun 19, 2026
11:23
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Sensitive multiplexed analysis of kinase activities and activity-based kinase identification
Kazuishi Kubota1, Rana Anjum, Yonghao Yu
1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Nature Biotechnology
|October 6, 2009
Summary
This study enhances the KAYAK mass spectrometry approach to simultaneously monitor multiple kinase signaling pathways. This method accurately profiles cancer cell line pathway activation and identifies specific kinases driving cancer progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Constitutive activation of kinase signaling pathways is a key feature of many cancers.
- Existing methods for monitoring kinase activity are often limited in scope or throughput.
Purpose of the Study:
- To extend the KAYAK approach for simultaneous monitoring of multiple kinase signaling pathways.
- To develop a sensitive and specific method for profiling kinase activity in cancer cells.
Main Methods:
- Utilized a mass spectrometry-based approach (KAYAK) to quantify phosphorylation of 90 synthetic peptides in a single reaction.
- Employed substrate competition to enhance kinase monospecificity.
- Applied hierarchical clustering and pharmacological inhibitors to analyze pathway alterations.
Main Results:
- Successfully monitored activities across multiple signaling pathways simultaneously in cancer cell lines.
- Demonstrated compatibility with nanogram to microgram amounts of cell lysate.
- Identified specific kinases and protein complex members responsible for phosphorylation events.
Conclusions:
- The enhanced KAYAK approach provides a powerful tool for comprehensive kinase activity profiling in cancer research.
- This method facilitates the understanding of signaling pathway dysregulation in various cancer types.
- Enables identification of potential therapeutic targets by pinpointing key kinases in cancer signaling.
